DSM Biologics - Moving to the Next Level of Technology

BioProcess International

Home | Downstream | Upstream | Manufacturing | Archive

Webcast Information

Moving to the Next Level of Technology

The protein manufacturing industry faces many challenges today – large stainless steel bioreactors cause downstream processing bottlenecks and come with a large footprint and high CAPEX. To address these challenges, DSM Biologics has developed the XD® Process Technology. This proprietary technology uses disposable systems to simplify the downstream process and lower CAPEX. In this on-demand webcast, Rolf Douwenga, Vice President of Global Research and Development for DSM Biologics, discusses:

Issues Facing Protein Manufacturing Industry
How DSM Addresses These Issues
In-depth Explanation of XD Process Technology

Join Douwenga as he details several case studies using XD Process Technology to enable a more flexible and simplified downstream process.

Targeted BPI Content

Many Considerations in Selecting Bioproduction Culture Media
BioProcess International, January 2009
Read more.

Maintaining Product Titer While Replacing Undefined Components in a CHO Culture System
BioProcess International, September 2009
Read more.

Monitoring ATP Status in the Metabolism of Production Cell Lines
BioProcess International, December 2008
Read more.

E. coli Secretion Technologies Enable Production of High Yields of Active Human Antibody Fragments
BioProcess International, September 2009
Read more.

Real-Time Bioreactor Monitoring of Osmolality and pH Using Near-Infrared Spectroscopy
BioProcess International, April 2009
Read more.

An Inoculum Expansion Process for Fragile Recombinant CHO Cell Lines
BioProcess International, September 2008
Read more.